T1	Participants 64 94	adults with systemic sclerosis
T2	Participants 214 257	among adults with systemic sclerosis (SSc).
T3	Participants 266 295	Forty-eight patients with SSc
T4	Participants 1518 1536	in adults with SSc
T5	Participants 1635 1652	patients with SSc
